CD20(+) tumor‐infiltrating immune cells and CD204(+) M2 macrophages are associated with prognosis in thymic carcinoma

Thymic carcinoma is a rare malignant disease with no standard systemic chemotherapy. The purpose of the present study was to investigate tumor‐infiltrating immune cells (TIIC) in the tumor microenvironment (TME), focusing on the impact of TIIC and program death‐ligand 1 (PD‐L1) expression on clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Jun, Kitano, Shigehisa, Motoi, Noriko, Ino, Yoshinori, Yamamoto, Noboru, Watanabe, Shunichi, Ohe, Yuichiro, Hiraoka, Nobuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293080/
https://www.ncbi.nlm.nih.gov/pubmed/32277550
http://dx.doi.org/10.1111/cas.14409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293080/
https://www.ncbi.nlm.nih.gov/pubmed/32277550
http://dx.doi.org/10.1111/cas.14409

Ejemplares similares